Announced
Financials
Sources
Tags
Pharmaceuticals
Ireland
Cross Border
Single Bidder
Acquisition
generic pharmaceuticals
Majority
Private
Private Equity
Friendly
Pending
Synopsis
Altaris Capital Partners, an investment firm focused exclusively on the healthcare industry, agreed to acquire the Generic Rx Pharmaceuticals unit of Perrigo, an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, for $1.5bn. "Given our experience in the pharmaceutical sector and track record of corporate carve-out transactions, we believe we are well-positioned to support the Rx business as it becomes a standalone company focused on its mission of developing and marketing affordable pharmaceutical products," Garikai Nyaruwata, Altaris Managing Director.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.